Dicerna Pharmaceuticals

Dicerna

Event Details

Banner Image
Investors & MediaHC Wainwright Bioconnect Conference analyst-led fireside chat

« Back

HC Wainwright Bioconnect Conference analyst-led fireside chat

Jan 11, 2021 at 6:00 AM EST

Our mission

We interfere with disease

Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.